OPKO HEALTH, INC.
CIK 944809 · last filed 2024-08-19
OPKO HEALTH, INC. is a corporate insider who has filed 34 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for WGS, was dated Sep 20, 2024. Across all open-market trades the lifetime net is −$24.4M, making them a net seller over the disclosed history. The firm reports its address in Miami, FL. 1,554 SEC filings were submitted jointly with PHILLIP MD ET AL FROST.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
34
-$24.39M
Filer Profile
MIAMI, FL 33137
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGSWW) Delisted | 10%+ Owner | 2,646,972 | $0.00 | $529 | -$24.70M | 12 | 2024-08-19 |
| VBI Vaccines Inc/BC (VBIV) Delisted | 10%+ Owner | 222,625 | $0.07 | $14.5K | $2.00M | 1 | 2017-11-01 |
| Sorrento Therapeutics, Inc. (SRNE) Delisted | 10%+ Owner | 2,161,759 | $0.00 | $1.1K | -$1.70M | 9 | 2013-11-27 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-20 | WGS | Notice (144) | −13,404 | -$548.0K | EDGAR |
| 2024-08-19 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −139,824 | -$4.76M | EDGAR |
| 2024-08-14 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −84,774 | -$2.90M | EDGAR |
| 2024-08-08 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −112,994 | -$3.56M | EDGAR |
| 2024-08-02 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −88,839 | -$2.98M | EDGAR |
| 2024-07-31 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −50,000 | -$1.69M | EDGAR |
| 2024-07-26 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −135,000 | -$4.56M | EDGAR |
| 2024-07-23 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −150,000 | -$4.95M | EDGAR |
| 2024-07-19 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −25,000 | -$823.2K | EDGAR |
| 2024-07-09 | GeneDx Holdings Corp. (WGSWW) Delisted | Sell (S) | −36,118 | -$1.02M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.